Kateřina Kaňková

1.6k total citations
78 papers, 1.2k citations indexed

About

Kateřina Kaňková is a scholar working on Clinical Biochemistry, Molecular Biology and Surgery. According to data from OpenAlex, Kateřina Kaňková has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Biochemistry, 18 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Kateřina Kaňková's work include Advanced Glycation End Products research (18 papers), Gestational Diabetes Research and Management (10 papers) and Pregnancy and preeclampsia studies (7 papers). Kateřina Kaňková is often cited by papers focused on Advanced Glycation End Products research (18 papers), Gestational Diabetes Research and Management (10 papers) and Pregnancy and preeclampsia studies (7 papers). Kateřina Kaňková collaborates with scholars based in Czechia, United Kingdom and Slovakia. Kateřina Kaňková's co-authors include Lukáš Pácal, Michal Beránek, Vladimı́r Znojil, Lýdie Izakovičová Hollá, Anna Vašků, Josef Tomandl, Jan Mužı́k, Jiřı́ Vácha, Jana Bělobrádková and Petr Beneš and has published in prestigious journals such as International Journal of Molecular Sciences, Diabetologia and Journal of Investigative Dermatology.

In The Last Decade

Kateřina Kaňková

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kateřina Kaňková Czechia 21 312 266 224 143 135 78 1.2k
H.J.M. van Rijn Netherlands 22 349 1.1× 60 0.2× 272 1.2× 53 0.4× 105 0.8× 59 1.5k
Corradino Motti Italy 20 306 1.0× 139 0.5× 225 1.0× 27 0.2× 72 0.5× 40 1.6k
Leopoldo Ardiles Chile 15 396 1.3× 132 0.5× 197 0.9× 24 0.2× 224 1.7× 56 1.4k
Yusuke Kaida Japan 24 252 0.8× 278 1.0× 148 0.7× 23 0.2× 61 0.5× 64 1.5k
Thati Madhusudhan Germany 18 497 1.6× 85 0.3× 75 0.3× 53 0.4× 226 1.7× 33 1.4k
Zhanmei Zhou China 23 743 2.4× 111 0.4× 102 0.5× 48 0.3× 175 1.3× 46 1.6k
Jonathan R. Diamond United States 23 437 1.4× 108 0.4× 170 0.8× 43 0.3× 280 2.1× 33 2.0k
J. W. Scholey Canada 20 327 1.0× 68 0.3× 270 1.2× 27 0.2× 203 1.5× 32 1.3k
Hyun Soon Lee South Korea 25 494 1.6× 101 0.4× 132 0.6× 31 0.2× 202 1.5× 61 1.6k
Sumant S. Chugh United States 21 777 2.5× 211 0.8× 211 0.9× 44 0.3× 229 1.7× 40 2.2k

Countries citing papers authored by Kateřina Kaňková

Since Specialization
Citations

This map shows the geographic impact of Kateřina Kaňková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kateřina Kaňková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kateřina Kaňková more than expected).

Fields of papers citing papers by Kateřina Kaňková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kateřina Kaňková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kateřina Kaňková. The network helps show where Kateřina Kaňková may publish in the future.

Co-authorship network of co-authors of Kateřina Kaňková

This figure shows the co-authorship network connecting the top 25 collaborators of Kateřina Kaňková. A scholar is included among the top collaborators of Kateřina Kaňková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kateřina Kaňková. Kateřina Kaňková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pácal, Lukáš, et al.. (2024). Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity. Journal of Clinical Medicine. 13(5). 1260–1260. 3 indexed citations
2.
Hubáček, Jaroslav A., et al.. (2022). Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?. Folia Biologica. 68(5-6). 159–179.
3.
Pelikánová, Terezie, Věra Adámková, Věra Lánská, et al.. (2021). The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics. Molecular Biology Reports. 48(8). 5873–5879. 8 indexed citations
4.
Janků, Petr, et al.. (2017). [Pregnancy outcomes in women with gestational diabetes: specific subgroups might require increased attention].. PubMed. 82(1). 16–23. 1 indexed citations
5.
Pácal, Lukáš, et al.. (2016). Effect of glucose variability on pathways associated with glucotoxicity in diabetes: Evaluation of a novel in vitro experimental approach. Diabetes Research and Clinical Practice. 114. 1–8. 27 indexed citations
6.
Pácal, Lukáš, Veronika Dvořáková, Jana Bělobrádková, et al.. (2016). Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes. Glycoconjugate Journal. 33(4). 591–598. 12 indexed citations
9.
Šebeková, Katarı́na, et al.. (2015). Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus. Biomedical Papers. 160(1). 70–75. 24 indexed citations
11.
Horová, Eva, et al.. (2012). Genetic and Functional Analyses of MRAS and HNF1A Genes in Diabetes and Diabetic Nephropathy. Folia Biologica. 58(3). 121–127. 5 indexed citations
12.
Tomandl, Josef, Lukáš Pácal, Jitka Řehořová, et al.. (2012). ADMA, SDMA and L-arginine/ADMA Ratio but not DDAH Genetic Polymorphisms are Reliable Predictors of Diabetic Nephropathy Progression as Identified by Competing Risk Analysis. Kidney & Blood Pressure Research. 36(1). 200–208. 14 indexed citations
13.
Salzman, Richard, et al.. (2010). High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma. International Journal of Clinical Oncology. 15(6). 565–570. 16 indexed citations
14.
Salzman, Richard, et al.. (2007). Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.. PubMed. 54(4). 321–5. 28 indexed citations
15.
Pácal, Lukáš, Petr Husa, Vladimı́r Znojil, & Kateřina Kaňková. (2007). HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population. Hepatology Research. 37(9). 740–747. 5 indexed citations
17.
Kaňková, Kateřina, et al.. (2002). Polymorphism 2184A/G in the gene encoding Receptor of AdvancedGlycation End products (RAGE) is a newly identified risk factorfor diabetic nephropathy. Diabetologia. 45. 1 indexed citations
18.
Hollá, Lýdie Izakovičová, et al.. (2001). Distribution of the Receptor for Advanced Glycation End Products Gene Polymorphisms in Patients With Chronic Periodontitis: A Preliminary Study. Journal of Periodontology. 72(12). 1742–1746. 31 indexed citations
19.
Kaňková, Kateřina, et al.. (2000). Lack of association between pregnancy-induced hypertension andfamilial thrombophilia in a Czech population. 5(4). 2 indexed citations
20.
Vašků, Vladimı́r, Anna Vašků, Lýdie Izakovičová Hollá, et al.. (1999). Interaction of five gene polymorphism at psoriasis. Journal of Investigative Dermatology. 113(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026